A New Decade Of Outsourcing: What Can We Expect? - Advice from Shawn Eisenberg, Executive Director, Manufacturing & Supply Chain, ImmunoGen
Source: Outsourced Pharma
Will the "Twenty-Twenties" be as exciting as they sound for our industry? For certain, nobody saw a coronavirus outbreak put outsourcing in such a public light.
Outsourced Pharma hosted a live, virtual discussion in June 2020 focusing on four key areas: continuous manufacturing; cell and gene therapy influences; new sponsor-CDMO service models; and "Supply Chain 4.0."
Here are excerpts from the opening comments of one of our speakers,Shawn Eisenberg, Executive Director, Manufacturing & Supply Chain, ImmunoGen.
VIEW THE VIDEO!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Outsourced Pharma? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
This website uses cookies to ensure you get the best experience on our website. Learn more